Literature DB >> 7877627

NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3.

H W Mages1, O Rilke, R Bravo, G Senger, R A Kroczek.   

Abstract

By analyzing the early genetic response of human T cells following mitogenic activation we have identified NOT, a member of the steroid/thyroid hormone family of receptors. NOT has all structural features of steroid/thyroid hormone receptors (C2C2 zinc-finger domain, ligand binding domain), but is rapidly and only very transiently expressed after cell activation, which is clearly at variance with classical steroid receptors such as glucocorticoid or estrogen receptors. NOT gene induction is independent of de novo protein synthesis, defining NOT as an immediate-early response gene. Short-lived NOT mRNA (4.2 kilobases) expression could be observed in vitro in a greater number of tissue types following activation by a variety of distinct stimuli. In vivo, NOT mRNA expression was detected exclusively in the brain, where a very strong signal was observed. By immunoblot analysis of human T cell lysates with NOT specific antisera two activation-dependent protein bands (66 and 59 kilodaltons) could be detected. NOT gene was localized to human chromosome 2q22-q23. Sequence comparison revealed that NOT is the human homolog of the murine NURR1 and rat RNR-1. Moreover NOT is closely related to NAK1/TR3, a previously identified human orphan steroid receptor. Several lines of evidence indicate that NOT and NAK1/TR3 form a distinct and exclusive subgroup of orphan steroid receptors, whose expression characteristics in vitro and in vivo resemble the expression of nonsteroid immediate-early transcription factors such as jun and fos. NOT and NAK1/TR3 thus may function as general coactivators of gene transcription rather than participate in the induction of specific target genes, as is the case with classical steroid receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7877627     DOI: 10.1210/mend.8.11.7877627

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  26 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 2.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

3.  Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system.

Authors:  O Saucedo-Cardenas; O M Conneely
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  Differential regulation of transcription by the NURR1/NUR77 subfamily of nuclear transcription factors.

Authors:  E P Murphy; A D Dobson; C Keller; O M Conneely
Journal:  Gene Expr       Date:  1996

5.  A divergent role of COOH-terminal domains in Nurr1 and Nur77 transactivation.

Authors:  S O Castillo; Q Xiao; Z Kostrouch; B Dozin; V M Nikodem
Journal:  Gene Expr       Date:  1998

6.  Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma.

Authors:  R I Brody; T Ueda; A Hamelin; S C Jhanwar; J A Bridge; J H Healey; A G Huvos; W L Gerald; M Ladanyi
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

7.  SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).

Authors:  Chunyu Wang; Ivan P Uray; Abhijit Mazumdar; Julie Ann Mayer; Powel H Brown
Journal:  Breast Cancer Res Treat       Date:  2012-01-03       Impact factor: 4.872

Review 8.  The aetiology of idiopathic Parkinson's disease.

Authors:  D B Ramsden; R B Parsons; S L Ho; R H Waring
Journal:  Mol Pathol       Date:  2001-12

Review 9.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Decreased NURR1 gene expression in patients with Parkinson's disease.

Authors:  Weidong Le; Tianhong Pan; Maosheng Huang; Pingyi Xu; Wenjie Xie; Wen Zhu; Xiong Zhang; Hao Deng; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2008-08-05       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.